Person

Bernard Schneider

Related publications (92)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Bernard Schneider

Graph Chatbot

Chat with Graph Search

Alpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease

Chondroitinase gene therapy improves upper limb function following cervical contusion injury

FOXO3 determines the accumulation of alpha-synuclein and controls the fate of dopaminergic neurons in the substantia nigra

Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1

Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration

A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity

Intracerebroventricular Injection of Adeno-Associated Virus 6 and 9 Vectors for Cell Type-Specific Transgene Expression in the Spinal Cord

A high-capacity cell macroencapsulation system supporting the long-term survival of genetically engineered allogeneic cells

Genetic engineering of cell lines using lentiviral vectors to achieve antibody secretion following encapsulated implantation

Large-Scale Chondroitin Sulfate Proteoglycan Digestion with Chondroitinase Gene Therapy Leads to Reduced Pathology and Modulates Macrophage Phenotype following Spinal Cord Contusion Injury